204 related articles for article (PubMed ID: 1473965)
1. The complement system in xenotransplantation.
Dalmasso AP
Immunopharmacology; 1992; 24(2):149-60. PubMed ID: 1473965
[TBL] [Abstract][Full Text] [Related]
2. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor.
Dalmasso AP; Platt JL
Transplantation; 1993 Nov; 56(5):1171-6. PubMed ID: 8249120
[TBL] [Abstract][Full Text] [Related]
3. Mouse-to-rabbit xenotransplantation: a new small animal model of hyperacute rejection mediated by the classical complement pathway.
Kerr SR; Dalmasso AP; Apasova EV; Chen SS; Kirschfink M; Matas AJ
Transplantation; 1999 Feb; 67(3):360-5. PubMed ID: 10030279
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of tissue injury in hyperacute xenograft rejection.
Platt JL
ASAIO J; 1992; 38(1):8-16. PubMed ID: 1554921
[TBL] [Abstract][Full Text] [Related]
5. Reaction of complement with endothelial cells in a model of xenotransplantation.
Dalmasso AP; Platt JL; Bach FH
Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):31-5. PubMed ID: 1718641
[TBL] [Abstract][Full Text] [Related]
6. Hyperacute xenograft rejection in the swine-to-human donor-recipient combination. In vitro analysis of complement activation.
Zhao Z; Termignon JL; Cardoso J; Chéreau C; Gautreau C; Calmus Y; Houssin D; Weill B
Transplantation; 1994 Jan; 57(2):245-9. PubMed ID: 8310516
[TBL] [Abstract][Full Text] [Related]
7. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection.
Fodor WL; Williams BL; Matis LA; Madri JA; Rollins SA; Knight JW; Velander W; Squinto SP
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11153-7. PubMed ID: 7526391
[TBL] [Abstract][Full Text] [Related]
8. The pathogenesis of hyperacute xenograft rejection.
Stevens RB; Platt JL
Am J Kidney Dis; 1992 Oct; 20(4):414-21. PubMed ID: 1415213
[TBL] [Abstract][Full Text] [Related]
9. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
[TBL] [Abstract][Full Text] [Related]
10. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model.
Platt JL; Fischel RJ; Matas AJ; Reif SA; Bolman RM; Bach FH
Transplantation; 1991 Aug; 52(2):214-20. PubMed ID: 1871792
[TBL] [Abstract][Full Text] [Related]
11. Xenograft rejection--molecular mechanisms and therapeutic implications.
Magee JC; Platt JL
Ther Immunol; 1994 Jan; 1(1):45-58. PubMed ID: 7584479
[TBL] [Abstract][Full Text] [Related]
12. [Complement in organ xenotransplantation].
Dalmasso AP
Rev Clin Esp; 1996 Mar; 196 Spec No():44-51. PubMed ID: 9206808
[No Abstract] [Full Text] [Related]
13. A synthetic dextran derivative inhibits complement activation and complement-mediated cytotoxicity in an in vitro model of hyperacute xenograft rejection.
Thomas H; Maillet F; Letourneur D; Jozefonvicz J; Kazatchkine MD; Fischer E
Transplant Proc; 1996 Apr; 28(2):593-4. PubMed ID: 8623290
[No Abstract] [Full Text] [Related]
14. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients.
Dalmasso AP; Vercellotti GM; Fischel RJ; Bolman RM; Bach FH; Platt JL
Am J Pathol; 1992 May; 140(5):1157-66. PubMed ID: 1580328
[TBL] [Abstract][Full Text] [Related]
15. [Organ xenotransplantation using human complement regulatory factor gene].
Hayashi S; Koike C; Isobe K; Yokoyama I; Takagi H
Nihon Rinsho; 1994 Sep; 52(9):2492-503. PubMed ID: 7967101
[TBL] [Abstract][Full Text] [Related]
16. Discordant xenografting: challenges and controversies.
Platt JL; Bach FH
Curr Opin Immunol; 1991 Oct; 3(5):735-9. PubMed ID: 1755990
[TBL] [Abstract][Full Text] [Related]
17. Key role of the alternate complement pathway in hyperacute rejection of rat hearts transplanted into fetal sheep.
Rajasinghe HA; Reddy VM; Hancock WW; Sayegh MH; Hanley FL
Transplantation; 1996 Aug; 62(3):407-11. PubMed ID: 8779691
[TBL] [Abstract][Full Text] [Related]
18. Antibody-mediated activation of the classical complement pathway in xenograft rejection.
Roos A; Daha MR
Transpl Immunol; 2002 May; 9(2-4):257-70. PubMed ID: 12180840
[TBL] [Abstract][Full Text] [Related]
19. Genetic engineering as an approach to xenotransplantation.
Bach FH
World J Surg; 1997; 21(9):913-6. PubMed ID: 9361504
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection.
Dalmasso AP; Vercellotti GM; Platt JL; Bach FH
Transplantation; 1991 Sep; 52(3):530-3. PubMed ID: 1716798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
